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Abstract
Objectives: Ischemia/reperfusion injury is characterized by endothelial cell activation leading to increased expression of adhesion
molecules such as inter-cellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, endothelial- and platelet-selectin
(E- and P-selectin), and to the subsequent recruitment of leukocytes. The aim of the present study was to investigate the respective effects of a
proinflammatory cytokine (tumor necrosis factor alpha , TNF-a), hypoxia and/or reoxygenation on adhesion molecule expression and natural
killer (NK) cell adhesion in an in vitro model of I/R. Methods: Human aortic endothelial cells (HAEC) were stimulated in vitro for 8h with
TNF-a (1000 U/ml) and exposed to hypoxia (1% O2), reoxygenation (21% O2) or different combinations thereof. Cell surface expression of
ICAM-1, VCAM-1 and E-/P-selectin on HAEC was analyzed by flow cytometry, and culture supernatants were tested for soluble adhesion
molecules by ELISA. Rolling adhesion of NK cells on HAEC was determined using a rotating assay. Results: Untreated HAEC
constitutively expressed ICAM-1 on their surface but neither expressed E-/P-selectin, VCAM-1, nor shedded soluble adhesion molecules.
Exposure of HAEC to hypoxia or hypoxia and reoxygenation did not upregulate cell surface expression or shedding of adhesion molecules.
In contrast, TNF-a significantly upregulated cell surface expression of ICAM-1, VCAM-1, and E-/P-selectin and led to the shedding of
ICAM-1 and E-selectin. Combined treatment of HAEC with TNF-a, hypoxia and reoxygenation reduced E-/P-selectin surface expression
and enhanced E-selectin shedding, but did not further influence ICAM-1 and VCAM-1. Soluble VCAM-1 was not detected. NK cell adhesion
on HAEC increased 4-fold after TNF-a stimulation, but was not affected by hypoxia or hypoxia and reoxygenation. Conclusions: Both the
expression of endothelial adhesion molecules and rolling NK cell adhesion was upregulated by TNF-a but not by hypoxia alone or hypoxia
followed by reoxygenation supporting the view that anti-inflammatory treatment may reduce ischemia/reperfusion injury.
q 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ischemia/reperfusion injury occurs in several clinical
situations including revascularization of coronary or
peripheral arteries, solid organ transplantation, severe
hypotension, and cardiac surgery employing extracorporal
circulation [1]. Reperfusion following ischemia represents
a double edged sword: on one hand it is crucial to re-
establish blood supply and salvage tissues from life
threatening damage, on the other hand it leads to
pathophysiological changes resembling inflammatory
responses in many regards. One of the earliest events
during ischemia/reperfusion injury is activation and
dysfunction of the endothelium. Endothelial cells exposed
to hypoxia in vitro release inflammatory mediators such
as tumor necrosis factor alpha (TNF-a) during reperfu-
sion, apparently due to a dysbalance between nitric oxid
(NO) and free radical production [2]. Nevertheless, the
role of O2-pressure changes as a cause of endothelial
activation and/or damage independently from
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cytokine-mediated cellular inflammatory reactions is still
not well defined. Ischemia/reperfusion-induced endothelial
changes are characterized by a dysbalance of the coagu-
lation system leading to obstruction of the microvascular
perfusion, complement activation, and a release of von
Willebrand factor. Moreover, several adhesion molecules
are upregulated. Endothelial- and platelet-selectin (E- and
P-selectin) bind to sugar residues on leukocytes. Members
of the immunoglobulin superfamily, namely inter-cellular
adhesion molecule (ICAM-1) and vascular adhesion
molecule (VCAM-1), bind to their ligands lymphocyte
function-associated antigen-1 (LFA-1) and very late anti-
gen-4 (VLA-4), respectively (reviewed in ref. [3]). On a
functional level, these adhesion molecules lead to the
recruitment of various leukocyte subpopulations, such as
neutrophiles and natural killer cells (NK cells), to the
endothelium and their subsequent migration into the tissue
[4,5]. Cellular infiltration into ischemic tissue and the
subsequent enhancement of local inflammatory reactions
result in the release of oxygen-derived free radicals,
proteolytic enzymes and inflammatory cytokines, all having
deleterious effects on endothelial and myocardial function
[4]. Furthermore, several clinical studies have demonstrated
the release of biologically active soluble adhesion mol-
ecules into the plasma of patients with coronary artery
disease [6], acute mycordial infarction [7], after cardiac
surgery [8] and transplantation [9]. However, the functional
role of soluble adhesion molecules in ischemia/reperfusion
remains to be elucidated.
Using an in vitro model of ischemia/reperfusion the aim
of the present study was to investigate the respective effects
of the proinflammatory cytokine TNF-a, hypoxia, and
reoxygenation on human aortic endothelial cells (HAEC)
with special regard to the surface expression and shedding
of adhesion molecules and the rolling adhesion of NK cells.
We found that neither hypoxia nor reoxygenation increased
the expression of adhesion molecules or rolling NK cell
adhesion in the absence of TNF-a. These findings indicate:
(1) that the induction of proinflammatory cytokines rather
than hypoxia itself is responsible for leukocyte recruitment
during ischemia/reperfusion; and (2) that therapeutic
approaches to limit leukocyte-mediated endothelial damage
during ischemia/reperfusion should aim at inhibiting the
upregulation and/or the function of adhesion molecules.
2. Materials and methods
2.1. Cell culture
2.1.1. Endothelial cells
HAEC were isolated from pieces of human aorta.
Adventitial tissue was roughly excised, the aortic lumen
cut open, and the endothelial side was incubated with M199
(Life Technologies, Basel, Switzerland) supplemented with
collagenase I (Worthington Biochemical Corporation,
Lakewood, NJ), 20 mM HEPES (Life Technologies) and
2% penicillin/streptomycin (Life Technologies) for 15 min
at 378C. Then the tissue was rinsed with HANKS balanced
salt solution (Kantonsapotheke, Zu¨rich, Switzerland), and
the resulting solution was filtered through a 22 mm cell
strainer to remove tissue debris. After centrifugation, the
cells were resuspended in 2 ml complete medium, M199
(Life Technologies) supplemented with 15% FCS (PAA
Laboratories GmbH, Linz, Austria), 20 mM HEPES, 100
U/ml Penicillin, 100 mg/ml Streptomycin, 1% MEM non-
essential amino acids (all Life Technologies), 100 mg/ml
heparin (Sigma, Buchs, Switzerland) and 50 mg/ml
endothelial cell growth supplement (BD Biosciences, Bed-
ford, MA) and seeded on fibronectin-coated (Fisher
Scientific AG, Wohlen, Switzerland) six-well-dishes
(Nunc A/S, Roskilde, Denmark). HAEC were used up to
passage 10 and their purity was regularly determined by
phase contrast microscopy, LDL-uptake (Biomedical Tech-
nologies Inc., Stoughton, MA/USA), and CD31 expression.
2.1.2. Natural killer cells (NK cells)
NK cell lines were generated as previously described
[10]. In brief, peripheral blood mononuclear cells (PBMC)
were isolated from heparinized peripheral blood of healthy
donors by Ficoll (Amersham Pharmacia Biotech, Uppsala,
Sweden) density gradient centrifugation. NK cells were
separated on a magnetic column by negative selection (NK
Cell MACS Isolation Kit, Miltenyi Biotech, Bergisch
Gladbach, Germany) and cultured in AIM-V medium
(Life Technologies) supplemented with 20% human plasma
obtained from healthy volunteers, MEM non-essential
amino acids, 1% penicillin/streptomycin, 1% HEPES (Life
Technologies) and 200 U/ml interleukin 2 (Cetus, Boston,
MA). Lethally irradiated PBMC (3000 rad) were added as
feeder cells during the 1st week. The purity of NK cell
populations was defined by a CD32/CD16þ/CD56þ phe-
notype as determined by flow cytometry and was routinely
.95%.
2.1.3. Hypoxia/reoxygenation (H/R)
HAEC were exposed to hypoxia (1% O2, 5% CO2 and
94% N2) for 8 h in a commercially available hypoxia
chamber (Coy Laboratory Products, Grass Lake, MI) at
378C in the presence or absence of TNF-a (1000 U/ml,
Sigma). Thereafter, the cells were washed once with
HANKS, normal cell culture medium was added, and
reoxygenation was performed in a humidified cell culture
incubator (21% O2, 5% CO2) at 378C for another 8 h.
Culture supernatants were collected and stored at2208C for
further analysis.
2.1.4. Antibodies
The following antibodies were used for flow cytometry:
MHC class I (DX17, kindly provided by L. Lanier,
University of California, San Francisco, CA), PECAM-1
(CD31, LCI-4 -6 and -7, kindly provided by P. Kilshaw, The
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Babraham Institute, Cambridge, UK), ICAM-1 (BBIG-I1,
R&D Systems, Minneapolis, MN), VCAM-1 (1G11.B1,
Neomarkers, CA) and E-/P-selectin (1.2B6 recognizing
both human E- and P-selectin, Serotec, Oxford, UK).
Negative controls were performed using irrelevant isotype-
matched antibodies (MOPC-21, Sigma, Saint Louis, MI).
2.2. Flow cytometry (FACS)
HAEC were detached by trypsinization (0.05% trypsin,
0.5 mM EDTA, Life Technologies), resuspended in FACS
buffer (HANKS, 0.1% bovine serum albumine) at a
maximum of 105 cells/tube and incubated for 30 min on
ice with saturating amounts of the indicated primary mouse
antibodies. After washing with FACS buffer, the cells were
incubated with secondary fluorescein isothiocyanate-con-
jugated goat anti-mouse antibodies (Boehringer Mannheim,
Mannheim, Germany) for 30 min on ice, washed again, and
analyzed on a FACScan (Becton Dickinson, Sunnyvale,
CA). Irrelevant isotype-matched antibodies were used as
negative controls and propidium iodide gating to exclude
dead cells. Low density lipoprotein (LDL)-uptake was
determined using a fluorescent probe (Dil-Ac-LDL, Bio-
medical Technologies Inc., Stoughton, MA), 2 mg/ml of
which was added to adherent HAEC for 4 h at 378C before
removal of the cells by trypsinization and analysis of LDL
uptake by flow cytometry.
2.3. Enzyme-linked immunosorbent assay (ELISA)
Cell free culture supernatants were analyzed in duplicate
for their content of soluble ICAM-1, VCAM-1 and E-
selectin by commercially available ELISA kits according to
the instructions of the manufacturer (R&D Systems,
Abdingdon, UK). To determine the protein concentration,
the test sample absorbances at OD450 nm were plotted
against a standard curve and expressed in ng/ml. The
detection limits were 0.35 ng/ml for soluble ICAM-1, 2.0
ng/ml for VCAM-1, and 0.1 ng/ml for E-selectin,
respectively.
2.4. Rotating adhesion assay
Rolling adhesion of NK cells on HAEC was analyzed
using a modified Stamper-Woodruff assay [11]. Briefly,
HAEC were grown to confluency in 30 mm culture dishes
within the limits of a 20 mm circle administered with a non-
toxic silicon oil coat (dimethylpolysiloxane; Sigma).
Monolayers were treated as indicated, carefully washed
with Weissman glucose buffer containing 5.55 mM glucose
(Sigma), and overlayed with 106 NK cells in 100 ml
Weissman glucose buffer supplemented with human
albumin (5 mg/ml, Fluka, Deisenhofen, Germany). The
dishes were rotated at 64 rpm in a shaker-incubator (Ku¨hner
AG, Birsfelden, Switzerland) at 378C, inducing a shear
stress of 0.7 dynes/cm2 at a radius of 0.6 cm from the center
on the endothelial monolayer. This shear stress corresponds
to the lower range of shear present in post capillary venules
in vivo. After 10 min the assay was stopped by prefixing all
cells for 2 min with 1% paraformaldehyde. The monolayers
were then gently washed with Weissman glucose buffer to
remove non-adherent NK cells, fixed for additional 20 min
and washed again. For quantification, five fields of 0.16
mm2 were defined at a distance of 0.6 cm from the center of
rotation and the number of adhering cells was counted by
light microscopy.
3. Results
3.1. Neither hypoxia nor hypoxia/reoxygenation induce
upregulation of adhesion molecules on HAEC
Resting HAEC constitutively expressed the adhesion
molecule ICAM-1, but not VCAM-1 or E-/P-selectin (Fig.
1). Stimulation with TNF-a (1000 U/ml) significantly
upregulated all adhesion molecules which were determined.
In contrast, neither hypoxia alone nor hypoxia followed by
reoxygenation had an influence on the cell surface
expression of adhesion molecules. Moreover, exposure of
HAEC to TNF-a in combination with hypoxia alone or
hypoxia followed by reoxygenation did not induce further
upregulation of adhesion molecules as compared with TNF-
a alone. In contrast, the combination of TNF-a and
hypoxia/reoxygenation led to a significant downregulation
of E-/P-selectin (P , 0:01) and a trend towards a decrease
of VCAM-1 expression (P ¼ 0:058), whereas ICAM-1
expression was unchanged.
3.2. Hypoxia and reoxygenation enhance TNF-a induced
shedding of ICAM-1 and E-selectin from HAEC
Next, we investigated whether adhesion molecules were
shed from the surface of HAEC upon treatment with TNF-a,
hypoxia or hypoxia/reoxygenation. Therefore, supernatants
obtained from in vitro cultures of HAEC were analyzed by
ELISA. Soluble adhesion molecules were not detected in
supernatans of resting HAEC. Accordingly, soluble ICAM-
1 was also absent in supernatants of hypoxia or hypoxia/r-
eoxygenation-treated cell cultures. In contrast, as shown in
Fig. 2, the mean concentration of soluble ICAM-1 was
3.31 ^ 0.25 ng/ml after activation of HAEC with TNF-a,
and even higher concentrations were found after treatment
with TNF-a and hypoxia (4.09 ^ 0.14 ng/ml) or hypoxia/
reoxygenation (4.32 ^ 0.08 ng/ml). E-selectin displayed a
shedding pattern similar to ICAM-1. Soluble E-selectin was
found after exposure of HAEC to TNF-a alone (0.88 ^ 0.12
ng/ml) or in combination with hypoxia (0.90 ^ 0.28 ng/ml),
and a combined treatment with TNF-a and hypoxia/
reoxygenation further increased the concentration of soluble
E-selectin in HAEC supernatants (1.47 ^ 0.51 ng/ml).
None of the treatments induced shedding of VCAM-1.
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Fig. 1. Cell surface expression of adhesion molecules. HAEC were exposed to TNF-a, hypoxia, hypoxia/reoxygenation (H/R) and different combinations
thereof. Expression of ICAM-1, VCAM-1 and E-/P-selectin was determined by flow cytometry. Numbers indicate mean fluorescence intensity. Negative
controls were performed with isotype-matches irrelevant antibodies (black histograms). Data are representative for at least four independant experiments.
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3.3. Rolling adhesion of NK cells on HAEC is not increased
by exposure to hypoxia or reoxygenation
To test whether hypoxia and/or reoxygenation have a
direct impact on leukocyte adhesion, rolling adhesion assays
using allogeneic human NK cells, which readily adhere to
resting HAEC, were performed (Fig. 3). Rolling NK-cell
adhesion to resting HAEC (median 19.25, range 10.25–
24.0) was increased following TNF-a stimulation (median
94.0, range 33.3–226.0), which is in line with the enhanced
surface expression of ICAM-1, VCAM-1 and E-/P-selectin
described above. On the contrary, exposure of HAEC to
hypoxia (median 18.0, range 6.5–25.85) even decreased
NK cell adhesion, and subsequent reoxygenation (median
21.5, range 12.9–36.75) did not lead to higher numbers of
adhering NK cells as compared with resting HAEC. In
addition, NK cell adhesion was not further increased on
HAEC exposed to a combination of TNF-a and hypoxia
(median 89.8, range 41.6–166.0) or TNF-a and hypoxia/
reoxygenation (median 105.25, range 22.9–179.0), as
compared with HAEC treated with TNF-a alone. In
summary, hypoxia alone does not display any additional
or synergistic effects on NK cell adhesion to HAEC in
relation to stimulation of HAEC with TNF-a alone.
4. Discussion
Endothelial activation and subsequent upregulation of
adhesion molecules is a well known phenomenon during
ischemia/reperfusion. However, there are contradictory
reports on the initial factor triggering endothelial activation;
hypoxia versus proinflammatory cytokines. This issue is of
importance for clinical decision making regarding ischemia
times and the design of therapeutical strategies to prevent
ischemia/reperfusion. Since the debate is still open, we
designed a study to evaluate the different impacts of oxygen
pressure changes and of the inflammatory stimulus TNF-a
using an in vitro model for ischemia/reperfusion.
Upregulation of cell surface adhesion molecules on
HAEC clearly depended on stimulation with TNF-a
whereas hypoxia and hypoxia/reoxygenation failed to
increase the expression of the adhesion molecules ICAM-
1, VCAM-1 and E-/P-selectin independently. These results
confirm and expand our previous findings showing that
hypoxia does not upregulate adhesion molecules on human
umbilical vein endothelial cells, but enhances lipopolysac-
charide-induced E-selectin expression on porcine aortic
endothelial cells [12]. In the present study, reoxygenation
additional to hypoxia was analyzed. This treatment did not
upregulate adhesion molecules on HAEC, but rather
decreased the cell surface expression of E-/P-selectin
confirming an earlier report on E-selectin expression on
umbilical vein endothelial cells [13]. One possible expla-
nation for this decrease consisted in shedding of the
adhesion molecules, as suggested by a previous report
showing that E-selectin shedding from umbilical vein
endothelial cells was indeed significantly enhanced by a
combination of TNF-a and hypoxia/reoxygenation [14].
Indeed, we also found that soluble E-selectin was present in
Fig. 2. Concentration of soluble ICAM and E-selectin in culture supernatants. HAEC were exposed to TNF-a, hypoxia, H/R and different combinations thereof.
Supernatants were analyzed for the concentration of soluble ICAM-1 and E-selectin by ELISA. Detection limits were 0.35 ng/ml for ICAM-1 and 0.2 ng/ml for
E-selectin, respectively (dotted line). Data represent one out of two independant experiments each performed in duplicate.
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supernatants of HAEC following stimulation with TNF-a
alone or in combination with exposure to hypoxia.
Additional reoxygenation further increased the shedding
of E-selectin. Therefore, E-selectin shedding may explain,
at least in part, the reduced amount of E-selectin detected on
the surface of HAEC after TNF-a and hypoxia/reoxygena-
tion. In contrast, there was no evidence for a similar
mechanism regulating the expression of the two other
adhesion molecules tested, ICAM-1 or VCAM-1.
The effect of adhesion molecule upregulation on
leukocyte recruitment to HAEC was tested in functional
NK cell adhesion experiments. Whereas neutrophil-
mediated tissue injury after adhesion and infiltration has
been cleary documented during ischemia/reperfusion [15],
little is known on a potentially additional role of NK cells.
NK cells are part of the leukocyte population infiltrating
inflammatory tissue and transplanted organs [5]. Since NK
cells are able to lyse endothelial cells [5], they might as well
mediate endothelial damage during ischemia/reperfusion. In
our experiments, a low number of NK cells adhered to
resting HAEC. Stimulation with TNF-a strongly increased
NK cell adhesion on HAEC, whereas hypoxia with or
without subsequent reoxygenation failed to increase NK cell
adhesion. In contrast, there was rather a trend towards
decreased NK cell adhesion on hypoxic endothelium. Since
TNF-a treatment of HAEC in combination with hypoxia/
reoxygenation reduced the surface levels of E-selectin and
VCAM-1, NK cell adhesion on HAEC, which was not
reduced by TNF-a and hypoxia/reoxygenation, seems to
depend primarily on ICAM-1/LFA-1 interactions. However,
this indirect evidence needs to be confirmed with blocking
assays using monoclonal antibodies specific for ICAM-1,
VCAM-1 and E-/P-selectin, respectively. In addition, since
allogeneic NK cells were used in this report future
experiments have to assess the susceptibility of ischemic
endothelial cells to autologous NK cell adhesion and lysis.
Taken together, our data support the notion that
endothelial activation in the setting of hypoxia/reoxygena-
tion, used as model for ischemia/reperfusion injury in vitro,
strongly depends on proinflammatory mediators such as
TNF-a. Several animal and clinical studies already tested
the feasibility of blocking inflammation and leukocyte
adhesion to prevent cardiovascular disease. It was suggested
to specifically block the nuclear factor-kB, a transcription
factor regulating the expression of ICAM-1 and VCAM-1 in
response to TNF-a [16], alternative approaches consist of
anti-TNF-a therapy [17] or inhibitors of cellular signalling
pathways such as Poly-(ADP)-Ribose-Polymerase [18].
Direct blocking of ICAM-1 or its ligands may represent at
least in part a potentially effective clinical treatment of
ischemia/reperfusion since in animal models the cerebral
infarction size was reduced by anti-ICAM-1 antibodies
administered during reperfusion [19]. However, in patients
with ischemic stroke, anti-ICAM-1 therapy was not
successful [19,20]. Accordingly, clinical trials of leuko-
cyte-adhesion blockade in myocardial infarction and
hemorrhagic shock were disappointing [21]. The reason
for the discrepancy between the positive results obtained in
animal models and the negative clinical trials are not fully
understood and currently under investigation. Another
perspective lies in the development of synthetic adhesion
molecule blockers, which may be less immunogenic than
antibodies and may be tolerated better.
The role of soluble adhesion molecules during
Fig. 3. Rolling NK cell adhesion. HAEC were exposed to TNF-a, hypoxia, H/R or combinations thereof and subsequently co-cultured with 106 NK cells for 10
min under shear stress. For quantification of adhering NK cells, five fields of 0.16 mm2 were counted. Individual data points from five independent experiments
are presented, the respective medians are indicated by horizontal lines.
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ischemia/reperfusion is not well defined. Theoretically, they
may contribute mechanistically to the disease and/or serve
as disease markers. However, preliminary clinical studies
revealed contradictory results on the latter. Soluble adhesion
molecules were elevated after coronary angioplasty and
acute myocardial infarction [22], and in individuals who
developed peripheral arteriosclerosis, baseline levels of
soluble ICAM were significantly higher compared to those
who remained healthy. However, the ranges were very tight
and therefore did not allow the use of soluble ICAM-1 as a
predictive marker [23]. In another study, soluble VCAM-1
was strongly elevated in patients with coronary artery
disease and death related to cardiovascular diseases,
whereas the correlations for E-selectin and ICAM-1 were
less stringent [24]. A meta analysis analyzing the value of
soluble adhesion molecules as predictor for coronary heart
disease came to the conclusion that measurements of soluble
adhesion molecules did not further add information for
diagnosis after adjustment for other cardiovascular risk
factors [25]. Thus, it seems that soluble adhesion molecule
concentrations in patient serum are only increased in a state
when cardiovascular damage is already clinically obvious.
Overall, the in vitro data obtained in the present study
indicate that the initial steps of ischemia/reperfusion leading
to endothelial cell activation mainly depend on inflamma-
tory responses and are not directly influenced by oxygen
pressure changes. Future studies are necessary to further
explore the potential role of soluble adhesion molecules
shed from activated endothelial cells and NK cell-mediated
damage during ischemia/reperfusion. Nevertheless, suc-
cessful therapy of ischemia/reperfusion may focus on
limiting the inflammatory reactions of the organism. To
date, adhesion molecule blockade did not show any clinical
benefit in treating ischemia/reperfusion, possibly because
leukocyte-induced tissue damage depends on parallel
mechanisms. Isolated blocking of only one arm seems to
deviate the system to alternative pathways, therefore
combined approaches of preventing endothelial activation
and blocking leukocyte adhesion will be necessary to avoid
inflammation and tissue damage during ischemia/reperfu-
sion injury.
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Appendix A. Conference discussion
Dr C. Yankah (Berlin, Germany): You are presenting adhesion
molecules as a marker for arteriosclerotic formation. Did you find out
other markers which are competitive to the adhesion molecules as a control
mechanism and therefore can be used to prevent the process of
arteriosclerosis on your model?
Dr Schmidt: The most investigated adhesion molecules in the context
of ischemia/reperfusion injury are indeed ICAM-1, the selectins and
VCAM-1. They are the ones responsible for adhesion of various kinds of
leukocytes which is a prerequisite to infiltration into the tissue. There are
several multi-centre studies under way to assess an association between
adhesion molecule serum levels and severity of arteriosclerosis; one study
aiming at blocking ICAM-1 in order to attenuate the ischemia/reperfusion
injury subsequent to stroke was disappointing so far.
Dr M. Deja (Katowice, Poland): I just wanted to know what was the
protocol for achieving hypoxia and reoxygenation in your situation? How
long was the hypoxia and what was the real method of insuring that this was
a strong enough hypoxic insult?
Dr Schmidt: Hypoxia and reoxygenation were performed for 8 h each in
a defined, closed hypoxia chamber equipped with an oxygen sensor
assuring constant hypoxia of 1%. The time period of 8 h was chosen
according to previous studies demonstrating the upregulation of the three
adhesion molecules investigated during this time.
Dr A. Haverich (Hannover, Germany): Not a question, but a comment.
I only rise to compliment the authors on this very nice study, for two
reasons, one, they had a reductionary approach in taking the question from
the cellular level into this tissue culture approach. It also shows that surgical
research can actually be done without going all the way down to molecular
genetics and still have a very clear and clean model as to study effects.
They’re very appropriate for the clinics.
Dr J. Vaage (Stockholm, Sweden): Let me just make a comment. Did
you find this to be a surprising result that you didn’t find any increase in
adhesion molecules in this model with hypoxia or in reoxygenation alone?
Dr Schmidt: Yes, we were surprised but in line with previously
published data. But this finding underlines the importance of dissecting a
complex in vivo process into its different components in vitro and also
demonstrated the high impact of secondary inflammatory reactions.
Dr Vaage: Do you believe that the findings would be different if you
had ischemia-reperfusion situation with blood and blood cells?
Dr Schmidt: Definitely, we were using an artificial in vitro system
which served to investigate hypoxia and reoxygenation effects rather than
ischemia/reperfusion injury. However, it will be interesting to establish an
experimental approach which is more closely related to the in vivo
situation.
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